Protagen, BioAnalytix and GeneWerk launch ProtaGene
ProtaGene will combine the know-how of three companies and will provide protein and gene analytic services for biological therapeutics and cell &...
EU orders up Valneva’s inactivated Covid-19 vaccine
The European Commission has approved an agreement with Valneva under which the French vaccine maker would supply up to 60 million doses of VLA2001,...
Novartis AG snags Gyroscope for US$1.5bn
The deal includes an upfront cash payment of $800m and up to $700m in cash upon the achievement of certain milestones. Gyroscope’s seed investor and...
Novo Holdings invests €86m in 21st.BIO
Established in 2020, 21st.BIO has been founded with a mission to support bioindustrial companies globally in upscaling from molecule innovation to...
Recordati bags EUSA to strengthen rare disease franchise
EUSA Pharma, which focuses on rare and niche oncology diseases, was founded in 2015. The company has a portfolio of four niche oncology products,...
From make-up to jet fuel: Breakthrough for Global Bioenergies
What does eye shadow have to do with biojet fuel? A lot, if you ask Global Bioenergies, a Evry-based biotech that is known for having developed a...
Early-stage ventures fighting AMR wanted!
The official application process for the Start-up competition @AMR Conference 2022 has started. Early-stage ventures fighting drug resistant...